Drug Approval | April 18, 2022
Amneal achieves second U.S. biosimilars approval with Alymsys
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Subscribe To Our Newsletter & Stay Updated
